Back

Trimetazidine and nicorandil decrease the increment of serum creatinine in patients with normal or slightly decreased renal function after undergoing elective percutaneous coronary intervention

3 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Coronary Intervention Complications ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Fengshuang An

Shandong University Qilu Hospital, Jinan (China)

6 More presentations in this session

Presentation thumbnail
Associate Professor D. Kim (Daejeon, KR)
Abstract Slides
Presentation thumbnail
Doctor K. Jha (Danville, US)
Abstract
Presentation thumbnail
Doctor Y. Watanabe (Matsudo, JP)
Abstract Slides
Presentation thumbnail
Doctor S. Shoji (Durham, US)
Abstract Slides
Presentation thumbnail
Doctor J. Geng (Hamburg, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Coronary Intervention

The Event

Event poster

ESC Congress 2019

3 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of contrast induced nephropathy in patients with normal renal function undergoing percutaneous coronary intervention - ADAPH score
20 March 2026
thumbnail
Congress Presentation
Renal and cardiovascular benefits of treatment with angiotensin receptor blockers in patients with hypertension and chronic kidney disease: A systematic review and meta-analysis
1 September 2019
thumbnail
Congress Presentation
The correlation between inflammatory biomarker and ejection fraction, and their evolution under the treatment with nebivolol vs bisoprolol in patients undergoing coronary angioplasty
2 March 2019
thumbnail
Congress Presentation
Cystatin C is better than creatine for prognostic evaluation in heart failure patients
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources